SCHEMBL25471877

SCHEMBL25471877

Cc1cc(C(=O)NCc2ccc(OCCCN3CCOCC3)c(Cl)c2)n(C)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ KDR P35968 2/20 0.47
▸ ALDH1A1 P00352 4/20 0.46
▸ MAPT P10636 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ HRH3 Q9Y5N1 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ HTR2A P28223 2/20 0.45
▸ HTR2C P28335 1/20 0.45
▸ HTR1A P08908 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ KMO O15229 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25471858 0.90 SLC5A7 (0.48) SMN1; SMN2KDRALDH1A1MAPTHTT
SCHEMBL25471866 0.89 MAPK14 (0.55) SMN1; SMN2KDRALDH1A1MAPTHTT
SCHEMBL25470500 0.88 KDR (0.44) SMN1; SMN2KDRALDH1A1MAPTHTT
SCHEMBL25471890 0.88 MAPK14 (0.46) SMN1; SMN2KDRALDH1A1MAPTHTT
SCHEMBL25471948 0.84 KDR (0.47) SMN1; SMN2KDRALDH1A1MAPTHTT
SCHEMBL25471907 0.83 KDR (0.46) SMN1; SMN2KDRALDH1A1MAPTHTT
SCHEMBL25471914 0.81 CSF1R (0.47) SMN1; SMN2KDRALDH1A1MAPTHTT
SCHEMBL25475339 0.81 KDM4E (0.43) SMN1; SMN2L3MBTL1ALDH1A1HTTNPC1
SCHEMBL25472073 0.81 KDM4E (0.43) SMN1; SMN2L3MBTL1ALDH1A1HTTHRH3
SCHEMBL25471922 0.80 HRH3 (0.56) SMN1; SMN2KDRALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12017997-B2 Host-targeted pan-respiratory antiviral small molecule therapeutics PROSETTA BIOSCIENCES, INC. (US) 2024-06-25 — — US disclosed
US-20230147603-A1 HOST-TARGETED PAN-RESPIRATORY ANTIVIRAL SMALL MOLECULE THERAPEUTICS PROSETTA BIOSCIENCES, INC. 2023-05-11 — — US disclosed
WO-2023069770-A1 NOVEL HOST-TARGETED PAN-RESPIRATORY ANTIVIRAL SMALL MOLECULE THERAPEUTICS PROSETTA BIOSCIENCES, INC. (US) 2023-04-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12017997-B2 Host-targeted pan-respiratory antiviral small molecule therapeutics MAVS, SARS1, ZC3HAV1 SMN1; SMN2 4475/4885L3MBTL1 2346/4885KDR 2966/4885
US-20230147603-A1 HOST-TARGETED PAN-RESPIRATORY ANTIVIRAL SMALL MOLECULE THERAPEUTICS MAVS, SARS1, ZC3HAV1 SMN1; SMN2 4475/4885L3MBTL1 2346/4885KDR 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback